Skip to main content

OPINION article

Front. Drug Saf. Regul.
Sec. Advanced Methods in Pharmacovigilance and Pharmacoepidemiology
Volume 4 - 2024 | doi: 10.3389/fdsfr.2024.1477516

Achieving Synchrony: Bridging the Gap Between Pharmaceutical Companies and Regulators on Safety Labeling Updates

Provisionally accepted
Tarek A. Hammad Tarek A. Hammad *Jean-Marie Heim Jean-Marie Heim
  • Takeda Pharmaceuticals Inc., Cambridge, United States

The final, formatted version of the article will be published soon.

    Keywords: drug safety, Pharmacovigilance, Safety Labeling Updates, Regulatory alignment, Synchrony Challenges

    Received: 07 Aug 2024; Accepted: 06 Sep 2024.

    Copyright: © 2024 Hammad and Heim. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Tarek A. Hammad, Takeda Pharmaceuticals Inc., Cambridge, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.